UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Control of ENaC ubiquitination

American journal of physiology. Renal physiology, 2024-08, Vol.327 (2), p.F265-F276

2024

Volltextzugriff (PDF)

Role of paraoxonase 3 in regulating ENaC‐mediated Na+ transport in the distal nephron

The Journal of physiology, 2024-02, Vol.602 (4), p.737-757

2024

Volltextzugriff (PDF)

Kcnma1 alternative splicing in mouse kidney: regulation during development and by dietary K + intake

American journal of physiology. Renal physiology, 2024-07, Vol.327 (1), p.F49-F60

2024

Volltextzugriff (PDF)

Estimating Phosphorescent Emission Energies in Ir III Complexes Using Large-Scale Quantum Computing Simulations

Angewandte Chemie International Edition, 2022-05, Vol.61 (19), p.e202116175

2022

Volltextzugriff (PDF)

Validation of commercially available antibodies directed against subunits of the epithelial Na+ channel

Physiological reports, 2023-01, Vol.11 (1), p.e15554-n/a

2023

Volltextzugriff (PDF)

Estimating Phosphorescent Emission Energies in IrIII Complexes Using Large‐Scale Quantum Computing Simulations

Angewandte Chemie International Edition, 2022-05, Vol.61 (19), p.e202116175-n/a

International ed. in English, 2022

Volltextzugriff (PDF)

Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain

Stem cells and development, 2016-04, Vol.25 (7), p.530-541

2016

Volltextzugriff (PDF)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia

Haematologica (Roma), 2021-12, Vol.106 (12), p.3115-3124

2021

Volltextzugriff (PDF)

Hyperstable Synthetic Mini-Proteins as Effective Ligand Scaffolds

ACS synthetic biology, 2023-12, Vol.12 (12), p.3608-3622

2023

Volltextzugriff (PDF)

Estimating Phosphorescent Emission Energies in IrIII Complexes Using Large‐Scale Quantum Computing Simulations

Angewandte Chemie, 2022-05, Vol.134 (19), p.n/a

2022

Volltextzugriff (PDF)

Purified chicken intestinal mucin attenuates Campylobacter jejuni pathogenicity in vitro

Journal of medical microbiology, 2010-08, Vol.59 (8), p.898-903

2010

Volltextzugriff (PDF)

Influence of Murine Background Strain on Renal Water Balance and Urine Concentration: FR-PO574

Journal of the American Society of Nephrology, 2024-10, Vol.35 (10S)

2024

Volltextzugriff (PDF)

Role of Paraoxonase 3 (PON3) in Regulating Epithelial Sodium Channel (ENaC)-Mediated Na+ Transport in Distal Nephron: FR-PO516

Journal of the American Society of Nephrology, 2023-11, Vol.34 (11S), p.546-546

2023

Volltextzugriff (PDF)

Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver

European journal of immunology, 2016-09, Vol.46 (9), p.2111-2120

2016

Volltextzugriff (PDF)

Functional in vivo effects of an ENaC Na + self inhibition-enhancing mutation

Physiology (Bethesda, Md.), 2024-05, Vol.39 (S1)

2024

Volltextzugriff (PDF)

Role of paraoxonase 3 (PON3) in regulating ENaC-mediated sodium transport in distal nephron

Physiology (Bethesda, Md.), 2023-05, Vol.38 (S1)

2023

Volltextzugriff (PDF)

Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-07, Vol.326 (3), p.230

2021

Volltextzugriff (PDF)

Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study

Arthritis & rheumatology (Hoboken, N.J.), 2024-09

2024

Volltextzugriff (PDF)

Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis

Cancer discovery, 2021-05, Vol.11 (5), p.1040-1051

2021

Volltextzugriff (PDF)

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

Annals of the rheumatic diseases, 2023-01, Vol.82 (1), p.154-160

2023

Volltextzugriff (PDF)

A First-in-Human Phase 1 Trial of NX-1607, a First-in-Class Oral CBL-B Inhibitor, in Patients with Advanced Malignancies Including DLBCL

Blood, 2023-11, Vol.142 (Supplement 1), p.3093-3093

2023

Volltextzugriff (PDF)

PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8 + T-cell Function

Cancer immunology research, 2019-02, Vol.7 (2), p.257-268

2019

Volltextzugriff (PDF)

A phase 1 adoptive cell therapy using drug-enhanced, tumor-infiltrating lymphocytes, DeTIL-0255, in adults with advanced malignancies

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS5602-TPS5602

2022

Volltextzugriff (PDF)

A first-in-human phase 1 trial of nx-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced solid tumor malignancies

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS2691-TPS2691

2022

Volltextzugriff (PDF)

COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade

Cancer Immunology, Immunotherapy, 2021-12, Vol.70 (12), p.3525-3540

2021

Volltextzugriff (PDF)

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(385)
Mit Volltextzugriff
(349)

Publikationsform

Sprache

Englisch
(400)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Control of ENaC ubiquitination

Role of paraoxonase 3 in regulating ENaC‐mediated Na+ transport in the distal nephron

Kcnma1 alternative splicing in mouse kidney: regulation during development and by dietary K + intake

Estimating Phosphorescent Emission Energies in Ir III Complexes Using Large-Scale Quantum Computing Simulations

Validation of commercially available antibodies directed against subunits of the epithelial Na+ channel

Estimating Phosphorescent Emission Energies in IrIII Complexes Using Large‐Scale Quantum Computing Simulations

Myeloid Engraftment in Humanized Mice: Impact of Granulocyte-Colony Stimulating Factor Treatment and Transgenic Mouse Strain

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia

Hyperstable Synthetic Mini-Proteins as Effective Ligand Scaffolds

Estimating Phosphorescent Emission Energies in IrIII Complexes Using Large‐Scale Quantum Computing Simulations

Purified chicken intestinal mucin attenuates Campylobacter jejuni pathogenicity in vitro

Influence of Murine Background Strain on Renal Water Balance and Urine Concentration: FR-PO574

Role of Paraoxonase 3 (PON3) in Regulating Epithelial Sodium Channel (ENaC)-Mediated Na+ Transport in Distal Nephron: FR-PO516

Tissue-resident Eomes(hi) T-bet(lo) CD56(bright) NK cells with reduced proinflammatory potential are enriched in the adult human liver

Functional in vivo effects of an ENaC Na + self inhibition-enhancing mutation

Role of paraoxonase 3 (PON3) in regulating ENaC-mediated sodium transport in distal nephron

Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial

Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 Study

Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis

Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial

A First-in-Human Phase 1 Trial of NX-1607, a First-in-Class Oral CBL-B Inhibitor, in Patients with Advanced Malignancies Including DLBCL

PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8 + T-cell Function

A phase 1 adoptive cell therapy using drug-enhanced, tumor-infiltrating lymphocytes, DeTIL-0255, in adults with advanced malignancies

A first-in-human phase 1 trial of nx-1607, a first-in-class oral CBL-B inhibitor, in patients with advanced solid tumor malignancies

COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade

Suchergebnisse filtern